GINS1 and invasive breast carcinoma: Ectopic expression assays showed that miR-101-5p attenuated BrCa malignant phenotypes by controlling several genes (e.g., HMGB3, ESRP1, GINS1, TPD52, SRPK1, VANGL1, and MAGOHB) whose expression levels are closely involved in the molecular pathogenesis of BrCa [16].